SHTDY
Sinopharm Group Co. Ltd.
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Last price
10.60
▲ 0.08 (0.76%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.59
Prev close
10.52
Day high
10.60
Day low
10.59
Volume
9.37K
Market cap
$6.66B
P/E (TTM)
6.24
52W range
10.00 – 14.87
Day trading desk
Gap from prior close
+0.67%
Prior close 10.52
VWAP
10.60
+0.04% from price
Relative volume
0.04×
Quiet session
Session range
0.09%
10.59 – 10.60
Position in range
100%
Near session high
ATR (14D)
0.30
2.86% of price
Prior day high
10.52
PDH
Prior day low
10.48
PDL
Bid / ask spread
—
Quote not published
Session volume
4.67K
Avg 133.22K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.28%
+1.1%
1M
-1.17%
-4.9%
3M
-5.53%
-8.6%
6M
-21.36%
-32.4%
YTD
-14.52%
-26.8%
1Y
-15.94%
-35.9%
3Y
-22.43%
-96.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SHTDY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$6.66B
Enterprise value$96.97B
Revenue (TTM)$574.27B
Gross profit$41.15B
EBITDA$19.14B
Net income$7.11B
EPS (TTM)$1.70
Free cash flow$-2.77B
Total cash$36.37B
Total debt$75.76B
Book value / share$20.32
Shares outstanding268.36M
Float254.92M
Short % of float—
Dividend yield4.74%
Beta (5Y)0.45
Valuation & profitability ratios
Trailing P/E6.24
Forward P/E—
PEG ratio2.26
Price / sales—
Price / book0.52
EV / revenue0.17
EV / EBITDA5.07
Gross margin7.17%
Operating margin2.18%
Profit margin1.24%
Return on equity8.10%
Return on assets2.63%
Debt / equity55.50
Current ratio1.40
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $575.17B | $584.51B | $596.57B | $552.15B | -1.6% |
| Operating revenue | $575.17B | $584.51B | $596.57B | $552.15B | -1.6% |
| Cost of revenue | $533.50B | $540.25B | $548.06B | $504.71B | -1.3% |
| Gross profit | $41.67B | $44.26B | $48.51B | $47.43B | -5.8% |
| Selling, general & admin | $24.02B | $25.57B | $26.15B | $24.90B | -6.1% |
| Total operating expense | $24.59B | $26.48B | $26.23B | $24.89B | -7.1% |
| Operating income | $17.08B | $17.77B | $22.28B | $22.54B | -3.9% |
| Net interest income | -$1.99B | -$2.33B | -$2.43B | -$3.19B | +14.3% |
| Pre-tax income | $14.80B | $14.00B | $19.51B | $18.56B | +5.7% |
| Tax provision | $3.97B | $3.58B | $4.50B | $4.22B | +10.8% |
| Net income | $7.16B | $7.05B | $9.05B | $8.53B | +1.5% |
| Net income to common | $7.16B | $7.05B | $9.05B | $8.53B | +1.5% |
| Basic EPS | 11.45 | 11.30 | 14.50 | 13.65 | +1.3% |
| Diluted EPS | 11.45 | 11.30 | 14.50 | 13.65 | +1.3% |
| EBIT | $17.10B | $16.73B | $22.47B | $22.08B | +2.2% |
| EBITDA | $21.39B | $21.47B | $26.90B | $26.25B | -0.4% |
| Basic shares | 624.13M | 624.13M | 624.13M | 624.13M | 0.0% |
| Diluted shares | 624.13M | 624.13M | 624.13M | 624.13M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $48.80B | $54.31B | $63.81B | $55.22B | -10.2% |
| Cash & short-term investments | $48.80B | $54.31B | $63.81B | $55.22B | -10.2% |
| Accounts receivable | $194.61B | $187.64B | $169.00B | $155.58B | +3.7% |
| Inventory | $63.34B | $62.35B | $60.03B | $60.93B | +1.6% |
| Total current assets | $346.80B | $347.45B | $336.84B | $319.41B | -0.2% |
| Property, plant & equipment | $16.26B | $17.61B | $18.05B | $17.79B | -7.7% |
| Goodwill & intangibles | $10.15B | $10.97B | $12.04B | $12.03B | -7.5% |
| Total assets | $390.36B | $392.83B | $383.39B | $364.78B | -0.6% |
| Total current liabilities | $246.73B | $250.38B | $241.49B | $234.96B | -1.5% |
| Current debt | $63.32B | $62.73B | $54.73B | $53.00B | +0.9% |
| Long-term debt | $3.65B | $8.64B | $13.83B | $11.75B | -57.8% |
| Total debt | $70.96B | $76.39B | $73.78B | $69.59B | -7.1% |
| Total liabilities | $256.20B | $266.14B | $263.08B | $254.71B | -3.7% |
| Retained earnings | $58.78B | $53.74B | $49.41B | $42.91B | +9.4% |
| Shareholder equity | $83.95B | $78.88B | $74.58B | $68.07B | +6.4% |
| Working capital | $100.07B | $97.07B | $95.34B | $84.44B | +3.1% |
| Net tangible assets | $73.81B | $67.91B | $62.54B | $56.04B | +8.7% |
| Shares issued | 3.12B | 3.12B | 3.12B | 3.12B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $14.80B | $14.00B | $19.51B | $18.56B | — | +5.7% |
| Depreciation & amortisation | $4.29B | $4.73B | $4.43B | $4.17B | — | -9.4% |
| Stock-based compensation | — | — | — | — | $0 | — |
| Change in working capital | -$2.75B | -$6.47B | -$3.86B | -$2.07B | — | +57.5% |
| Operating cash flow | $14.14B | $11.55B | $17.17B | $20.96B | — | +22.5% |
| Capital expenditure | -$1.62B | -$1.97B | -$2.34B | -$2.42B | — | +17.8% |
| Investing cash flow | -$963.89M | -$3.75B | -$944.53M | -$3.59B | — | +74.3% |
| Dividends paid | -$2.12B | -$2.71B | -$2.56B | -$2.34B | — | +21.8% |
| Financing cash flow | -$18.69B | -$17.29B | -$7.64B | -$5.69B | — | -8.1% |
| Free cash flow | $12.52B | $9.58B | $14.84B | $18.55B | — | +30.7% |
| End cash position | $48.80B | $54.31B | $63.81B | $55.22B | — | -10.2% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $48.80B | $35.24B | $54.31B | +38.5% |
| Cash & short-term investments | $48.80B | $35.24B | $54.31B | +38.5% |
| Accounts receivable | $194.61B | $235.34B | $187.64B | -17.3% |
| Inventory | $63.34B | $66.81B | $62.35B | -5.2% |
| Total current assets | $346.80B | $375.19B | $347.45B | -7.6% |
| Property, plant & equipment | $16.26B | $18.85B | $17.61B | -13.7% |
| Goodwill & intangibles | $10.15B | $8.83B | $10.97B | +14.9% |
| Total assets | $390.36B | $420.33B | $392.83B | -7.1% |
| Total current liabilities | $246.73B | $279.85B | $250.38B | -11.8% |
| Current debt | $63.32B | $85.91B | $62.73B | -26.3% |
| Long-term debt | $3.65B | $4.44B | $8.64B | -17.8% |
| Total debt | $70.96B | $94.90B | $76.39B | -25.2% |
| Total liabilities | $256.20B | $291.07B | $266.14B | -12.0% |
| Retained earnings | $58.78B | $55.09B | $53.74B | +6.7% |
| Shareholder equity | $83.95B | $80.23B | $78.88B | +4.6% |
| Working capital | $100.07B | $95.34B | $97.07B | +5.0% |
| Net tangible assets | $73.81B | $71.40B | $67.91B | +3.4% |
| Shares issued | 3.12B | 3.12B | 3.12B | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $591.00B | +2.8% |
| Next year | — | — | $619.29B | +4.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.00%
Institutions holding4
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
10.64
-0.41% from price
SMA 20
10.85
-2.34% from price
SMA 50
10.76
-1.45% from price
SMA 100
11.36
-6.69% from price
SMA 200
12.27
-13.58% from price
EMA 12
10.70
-0.94% from price
EMA 26
10.79
-1.72% from price
EMA 50
10.91
-2.88% from price
RSI (14)
43.2
Neutral
MACD (12,26,9)
-0.09
Hist -0.03
ATR (14)
0.30
2.86% of price
Realised vol 30D
21.0%
Annualised
Bollinger upper
11.33
20, 2σ
Bollinger lower
10.38
20, 2σ
50 / 200 cross
Death
10.76 vs 12.27
Trend bias
Below 200
-13.58%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.34
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
21.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-28.5%
Peak to trough
Max drawdown 5Y
-43.9%
Peak to trough
ATR 14
0.30
2.86% of price
Beta (reported)
0.45
5Y monthly, from filing
Dividends & splits
Forward rate$0.50 / yr
Forward yield4.74%
5-year avg yield4.43%
Payout ratio29.43%
Ex-dividend dateJun 24, 2026
Next pay dateSep 8, 2026
Last split—
Split date—
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.